Delayed Sealing of WATCHMAN Device Shunt
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
lthough left atrial appendage closure is an alternative to warfarin use in atrial fibrillation patients with a high bleeding risk, long-term outcome data in real-world practice are still limited. We describe a delayed shunt on the WATCHMAN fabric membrane and associated stroke at 7 months after the procedure. This shunt on the device surface disappeared at 15 months on the follow-up transesophageal echocardiogram.
Abstract
lthough left atrial appendage closure is an alternative to warfarin use in atrial fibrillation patients with a high bleeding risk, long-term outcome data in real-world practice are still limited. We describe a delayed shunt on the WATCHMAN fabric membrane and associated stroke at 7 months after the procedure. This shunt on the device surface disappeared at 15 months on the follow-up transesophageal echocardiogram.
참고문헌 (9)
- Wolf PA, "Atrial fibrillation: a major contributor to stroke in the elderly. The Framingham Study", Arch Intern Med, 147, pp.1561~1564 (1987)
- Boersma LV, "Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry", Eur Heart J, 37, pp.2465~2474 (2016)
- Reddy VY, "Percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation: 2.3-Year Follow-up of the PROTECT AF (Watchman Left Atrial Appendage System for Embolic Protection in Patients with Atrial Fibrillation) trial", Circulation, 127, pp.720~729 (2013)
- De Backer O, "Percutaneous left atrial appendage occlusion for stroke prevention in atrial fibrillation: an update", Open Heart, 1, pp.e000020~ (2014)
- Kim JS, "Left atrial appendage occlusion in non-valvular atrial fibrillation in a Korean Multi-Center Registry", Circ J, 80, pp.1123~1130 (2016)
- Youn JC, "Watch out for the WATCHMAN", Eur Heart J, 36, pp.1648~ (2015)
- Reddy VY, "Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry", Circulation, 123, pp.417~424 (2011)
- Holmes DR, Jr., "Prospective randomized evaluation of the Watchman Left Atrial Appendage Closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial", J Am Coll Cardiol, 64, pp.1~12 (2014)
- Meier B, "EHRA", EAPCI expert consensus statement on catheter-based left atrial appendage occlusion, 2014, pp.16, 1397~1416
